Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 9 chart positions in 9 markets.
By chart position
- 🇮🇳IN · Medicine#4330K to 100K
- 🇸🇪SE · Medicine#1611K to 10K
- 🇰🇷KR · Medicine#1711K to 10K
- 🇫🇮FI · Medicine#4010K to 30K
- 🇨🇱CL · Medicine#106500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
22K to 83K🎙 ~2x weekly·47 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
45K to 165K🇮🇳61%🇫🇮18%🇸🇪6%+6 more - Active Followers
Loyal subscribers who consistently listen
18K to 66K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHosts
Recent guests
Recent episodes
Bispecifics ate CAR-T's lunch: a multiple myeloma debate
Jun 11, 2026
56m 28s
Episode 47: Cult-Like Thinking in BMT
Jun 4, 2026
45m 23s
Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology
Apr 13, 2026
1h 01m 29s
HLH: From Chaos to Clarity... and Back to Chaos!
Mar 20, 2026
1h 04m 40s
An Exercise in Uncertainty with Jonathan Gluck
Feb 10, 2026
46m 18s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/11/26 | Bispecifics ate CAR-T's lunch: a multiple myeloma debate✨ | multiple myelomaCAR-T therapy+4 | Manni Mohyuddin, MD | Nature Reviews CommentaryCARTITUDE-4+6 | — | multiple myelomaCAR-T+5 | — | 56m 28s | |
| 6/4/26 | Episode 47: Cult-Like Thinking in BMT✨ | cult-like thinkinghematology+3 | Tate FeeneyAaron Goodman | The impact of cult behavior on haematopoietic cell transplant practices: believers and non-believers | — | cult behaviorhematopoietic cell transplant+3 | — | 45m 23s | |
| 4/13/26 | Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology✨ | oncologyclinical trials+4 | Dr. Eddie CliffDr. Roberta Demichelis+1 | Common Sense Oncology | AustraliaMexico+1 | ASH 2025oncology+5 | — | 1h 01m 29s | |
| 3/20/26 | HLH: From Chaos to Clarity... and Back to Chaos!✨ | hemophagocytic lymphohistiocytosishematology+5 | Justin Kaner, MDMadeleine Ochs, PharmD, BCOP+1 | hemophagocytic lymphohistiocytosis (HLH) | — | HLHhemophagocytic lymphohistiocytosis+5 | — | 1h 04m 40s | |
| 2/10/26 | An Exercise in Uncertainty with Jonathan Gluck✨ | uncertaintycancer+4 | Jonathan Gluck | Penguin Random HouseAn Exercise in Uncertainty: A Memoir of Illness and Hope | — | uncertaintymultiple myeloma+5 | — | 46m 18s | |
| 12/17/25 | ASH Leukemia Review: the more we learn, the less we know!✨ | leukemiaASH abstracts+3 | Dr. Justin Kaner | Weill Cornell MedicinePARADIGM+5 | — | leukemiaASH 2025+3 | — | 1h 23m 23s | |
| 12/9/25 | RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy✨ | PARADIGM studyASH 2025+3 | — | PARADIGMPARADIGM study | — | PARADIGMASH 2025+3 | — | 41m 25s | |
| 11/25/25 | MajesTEC-3 and ASH 2025: Let's get "TEC"nical✨ | myelomaASH abstracts+3 | Manni Mohyuddin | MajesTEC-3ASH | — | myelomaMajesTEC-3+6 | — | 1h 09m 31s | |
| 10/24/25 | Episode 40: Coffee and Community Hematology✨ | community hematologyinnovative research models+3 | — | community hematologyacademic practices+1 | — | community hematologyresearch models+3 | — | 51m 20s | |
| 10/9/25 | Chill For 5: The Febrile Neutropenia Survival Guide✨ | febrile neutropeniapatient management+3 | — | Chill For 5: The Febrile Neutropenia Survival Guide | — | febrile neutropeniaantibiotics+3 | — | 49m 25s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 9/10/25 | Episode 38: Prophy and Pints!✨ | antimicrobial prophylaxishematology patients+5 | — | hematology | — | prophylaxisantimicrobial+7 | — | 49m 40s | |
| 7/11/25 | Episode 37: Spilling Drinks over Cytarabine Dosing✨ | cytarabine dosingAML consolidation+3 | — | cytarabineHunault, et al. NEJM. 2025 | — | cytarabineAML+5 | — | 58m 36s | |
| 5/5/25 | CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined | This is a special encore video presentation of Anthony and Bernie teaming up with the Common Sense Oncology Journal Club series to discuss the SWOG1826 and STARGLO clinical trials. Tycel Phillips, MD, and Manju Sengar, MD join Anthony and Bernie for a great discussion of the trials and how they should impact practice! Join the Common Sense Oncology movement here! https://commonsenseoncology.org/ | — | ||||||
Showing 13 of 2
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
10 placements across 9 markets.
Chart Positions
10 placements across 9 markets.